Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer

Gemcitabine has been reported to be a potent radiosensitiser in human pancreatic cell lines. This study was conducted to evaluate the efficacy and toxicity of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer. In all, 42 patients with pancreatic cancer that was unresectab...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Okusaka, T, Ito, Y, Ueno, H, Ikeda, M, Takezako, Y, Morizane, C, Kagami, Y, Ikeda, H
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2004
Konular:
Clinical
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2364779/
https://ncbi.nlm.nih.gov/pubmed/15226765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602001
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller